These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 31789394

  • 41. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X, Li Z, Zhao L, Quan J, Zhou L, Xu J, Xu W, Guan X, Li H, Yang S, Gui Y, Lai Y.
    Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
    [Abstract] [Full Text] [Related]

  • 42. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C, Wang S, Ye ZQ, Chen ZQ.
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
    [Abstract] [Full Text] [Related]

  • 43. PinX1 represses renal cancer angiogenesis via the mir-125a-3p/VEGF signaling pathway.
    Hou P, Li H, Yong H, Chen F, Chu S, Zheng J, Bai J.
    Angiogenesis; 2019 Nov; 22(4):507-519. PubMed ID: 31254127
    [Abstract] [Full Text] [Related]

  • 44. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
    Lin H, Pan JC, Zhang FM, Huang B, Chen X, Zhuang JT, Wang H, Mo CQ, Wang DH, Qiu SP.
    Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
    [Abstract] [Full Text] [Related]

  • 45. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y, Gong Y, Ning X, Peng D, Liu L, He S, Gong K, Zhang C, Li X, Zhou L.
    J Exp Clin Cancer Res; 2018 Nov 14; 37(1):276. PubMed ID: 30428910
    [Abstract] [Full Text] [Related]

  • 46. Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma.
    Zhao G, Na R, Li L, Xiao H, Ding N, Sun Y, Han R.
    Oncol Rep; 2017 Aug 14; 38(2):1021-1028. PubMed ID: 28656230
    [Abstract] [Full Text] [Related]

  • 47. miR‑133b affects cell proliferation, invasion and chemosensitivity in renal cell carcinoma by inhibiting the ERK signaling pathway.
    Xu Y, Ma Y, Liu XL, Gao SL.
    Mol Med Rep; 2020 Jul 14; 22(1):67-76. PubMed ID: 32377748
    [Abstract] [Full Text] [Related]

  • 48. MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
    Qin Z, Wei X, Jin N, Wang Y, Zhao R, Hu Y, Yan W, Li J, Zhou Q.
    Artif Cells Nanomed Biotechnol; 2018 Dec 14; 46(8):1920-1925. PubMed ID: 29130345
    [Abstract] [Full Text] [Related]

  • 49. Dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma.
    Chen YS, Meng F, Li HL, Liu QH, Hou PF, Bai J, Zheng JN.
    Oncotarget; 2016 Dec 20; 7(51):84299-84313. PubMed ID: 27732931
    [Abstract] [Full Text] [Related]

  • 50. microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma.
    Lai Y, Zhao L, Hu J, Quan J, Chen P, Xu J, Guan X, Lai Y, Ni L.
    Mol Med Rep; 2018 Jun 20; 17(6):8510-8517. PubMed ID: 29693121
    [Abstract] [Full Text] [Related]

  • 51. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.
    Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC, Tan TH, Colburn NH.
    Mol Cell Biol; 2006 Feb 20; 26(4):1297-306. PubMed ID: 16449643
    [Abstract] [Full Text] [Related]

  • 52. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H, Zhu D, Zheng Z, Cai Y, Chen Z, Xie W.
    Clin Transl Oncol; 2019 Jul 20; 21(7):939-949. PubMed ID: 30607788
    [Abstract] [Full Text] [Related]

  • 53. Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma.
    Jin L, Quan J, Pan X, He T, Hu J, Li Y, Gui Y, Yang S, Mao X, Chen Y, Lai Y.
    Mol Med Rep; 2017 Nov 20; 16(5):7072-7079. PubMed ID: 28901455
    [Abstract] [Full Text] [Related]

  • 54. Overexpression of miR‑21 is involved in acute monocytic leukemia‑associated angiogenesis by targeting IL‑12.
    He XP, Chen P, Yang K, Liu B, Zhang Y, Wang F, Guo Z, Liu XD, Lou JX, Chen HR.
    Mol Med Rep; 2018 Oct 20; 18(4):4122-4128. PubMed ID: 30106099
    [Abstract] [Full Text] [Related]

  • 55. MicroRNA-21 is overexpressed in renal cell carcinoma.
    Lv L, Huang F, Mao H, Li M, Li X, Yang M, Yu X.
    Int J Biol Markers; 2013 Jun 28; 28(2):201-7. PubMed ID: 23558936
    [Abstract] [Full Text] [Related]

  • 56. microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
    Yoshino H, Yonemori M, Miyamoto K, Tatarano S, Kofuji S, Nohata N, Nakagawa M, Enokida H.
    Oncotarget; 2017 Mar 28; 8(13):20881-20894. PubMed ID: 28152509
    [Abstract] [Full Text] [Related]

  • 57. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C, Li Z, Chen P, Quan J, Pan X, Zhao L, Zhou L, Lai Y, He T, Xu W, Xu J, Guan X, Li H, Yang S, Hu Y, Lai Y.
    Life Sci; 2018 Sep 15; 209():481-489. PubMed ID: 30138594
    [Abstract] [Full Text] [Related]

  • 58. HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma.
    Li H, Wang X, Zhang C, Cheng Y, Yu M, Zhao K, Ge W, Cai A, Zhang Y, Han F, Hu Y.
    Cancer Lett; 2018 Sep 28; 432():121-131. PubMed ID: 29890207
    [Abstract] [Full Text] [Related]

  • 59. LncRNA NBAT1 suppresses cell proliferation and migration via miR-346/GSK-3β axis in renal carcinoma.
    Xue S, Wang S, Li J, Guan H, Jiang S, Guo Y, Li Q.
    IUBMB Life; 2019 Nov 28; 71(11):1720-1728. PubMed ID: 31298469
    [Abstract] [Full Text] [Related]

  • 60. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G, Chong T, Xiang X, Yang J, Li H.
    Oncol Rep; 2017 Oct 28; 38(4):1995-2002. PubMed ID: 28849086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.